No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / mortality
-
Chemotherapy, Adjuvant / economics
-
Cost-Benefit Analysis
-
Cyclophosphamide / therapeutic use
-
Doxorubicin / therapeutic use
-
Female
-
Fluorouracil / therapeutic use
-
Humans
-
Methotrexate / therapeutic use
-
Survival Rate
Substances
-
Doxorubicin
-
Cyclophosphamide
-
Fluorouracil
-
Methotrexate